Skip to main content

Feminizing Urethroplasty — Urethral Shortening and Feminizing Repositioning

Feminizing urethroplasty is a core component of every feminizing genital GAS (vaginoplasty and vulvoplasty): the long male urethra (~18–20 cm) is shortened to a female-appropriate length (~3–4 cm) and the neomeatus is repositioned from the glans tip to the vestibule between the neoclitoris and the vaginal introitus, producing a downward-directed urinary stream.[1][2]

This is the dedicated atlas page. For the cohort-level framework, see Feminizing Gender-Affirming Surgery. For the host operation, see Penile Inversion Vaginoplasty. For the clitoro-urethral-complex framework, see Clitoroplasty (Preputial-Skin Flap, Dorsal NVB).

Anatomic Foundation​

Male urethra (preoperative). Four segments totalling ~18–20 cm:[3]

  • Prostatic (~3–4 cm) — transitional epithelium.
  • Membranous (~1–2 cm) — through the external urethral sphincter / urogenital diaphragm; the continence zone, preserved unchanged during feminizing urethroplasty.
  • Bulbar (~3–4 cm) — within the bulb of corpus spongiosum.
  • Pendulous (penile) (~10–15 cm) — within the penile-shaft corpus spongiosum to the glanular meatus.

The corpus spongiosum surrounds the bulbar and pendulous segments, providing vascular supply and structural bulk; the rhabdosphincter at the membranous urethra is the primary mechanism of voluntary continence.[3]

Female target anatomy. Length ~3–4 cm; opens in the vestibule between clitoris (superior) and introitus (inferior); short length produces a downward-directed seated stream.[3][4]

Reconstructive transformation. Three simultaneous goals:[2][5]

  1. Shorten the urethra from ~18–20 cm → ~3–4 cm by excising the pendulous segment.
  2. Reposition the neomeatus to the vestibule between neoclitoris and introitus.
  3. Create a patent, non-stenotic neomeatus producing a downward-directed stream without spraying.

Surgical Technique — Standard Penile Inversion Vaginoplasty​

Integral to the overall PIV procedure; details vary by surgeon but the core steps are consistent.[5][6][7]

  1. Urethral dissection from corpora — during penile disassembly, the urethra with its surrounding corpus spongiosum is dissected free from the ventral groove between the corpora cavernosa, from glans distally to penoscrotal junction proximally, preserving spongiosal blood supply ("dismembering of the urethra from the corpora" — Baudet step 6).[6][7]
  2. Urethral transection and shortening — distal penile urethra transected at the glans (original meatus excised with the glans tissue used for clitoroplasty); pendulous segment excised, leaving the bulbar + membranous segments + short distal stump for the neomeatus. Final urethra ~3–5 cm bladder neck to neomeatus, matching cisgender female length.[1][5]
  3. Spatulation — distal stump spatulated ventrally (longitudinal incision, 0.5–1.5 cm) to convert the circular lumen to a wider elliptical opening that resembles the female meatus and prevents meatal stenosis.[5][8]
  4. Neomeatus creation and positioning — spatulated end sutured to surrounding skin / mucosal tissue at the vestibular position, between neoclitoris (superior) and introitus (inferior), to produce a downward-directed seated stream.[2][5][6][7]
  5. Relationship to the clitoro-urethral complex — neomeatus and neoclitoris form the clitoro-urethral complex together; urethra typically transected ~1 cm distal to the complex.[8]
  6. Catheter — Foley 14–16 Fr through the neomeatus for 5–14 days to allow anastomotic healing and prevent stenosis; some surgeons use suprapubic in addition.[6][9]

Technique-specific variants​

VariantUrethral fateNeomeatusUnique consideration
Standard PIVPendulous excised; bulbar / membranous preservedSpatulated distal stump sutured to vestibuleMost common; meatal stenosis 4–40%[1][2]
Amend / TübingenUrethra incorporated into the ventral penile-skin flap rather than completely separated; assembled neovagina inverted as a compositePositioned at anatomic locationn = 24; depth 11 cm; 97% good/excellent neoclitoral sensation; no major complications at 39.7-mo median follow-up[6]
Perovic penile-disassemblyLong vascularised urethral flap embedded into the penile-skin tube to line the deep canal; separate shorter segment for neomeatusSeparate shorter segmentDual urethral use; mucosal canal surface; n = 89, 87% good cosmetic / functional[10]
Brassard urethral-flap clitoroplastyUrethra used for clitoral hood via dorsal urethrotomy; transected ~1 cm distal to clitoro-urethral complexSame vestibularMore urethral manipulation; potentially higher stenosis risk[8]
Zero-depth vulvoplastySame shortening; no canalSame vestibularSimpler procedure; same urethral principles
Peritoneal-flap / IntestinalSame shorteningSame vestibularUrethral management identical to PIV

Raigosa five-step framework​

Raigosa et al. characterise feminizing genital surgery as five major steps common to every technique: orchiectomy → penile disassembly → neovaginal-cavity creation → urethral meatus repositioning → clitorolabioplasty.[11]

Postoperative Neourethral Anatomy​

Essential for long-term gynecologic / primary-care management:[4][12]

  • Neourethra = native prostatic + membranous + bulbar urethra (unchanged) + short distal segment to neomeatus.
  • Prostate gland remains in situ, anterior to the neovaginal canal — prostate examinations are performed vaginally, not rectally.[12]
  • External urethral sphincter preserved; voluntary continence is maintained.
  • Neomeatus in vestibule between neoclitoris and introitus, sometimes partially obscured by clitoral hood or labial tissue.[4]
  • Higher UTI rate postoperatively — the shortened urethra reduces the ascending-infection barrier, analogous to cisgender female anatomy.[12]
  • Residual corpus spongiosum around the neomeatus can cause periurethral fullness or rare arousal-related engorgement.[4]

Complications and the Surgeon-vs-Patient Reporting Gap​

ComplicationSurgeon-reportedPatient-reportedNotes
Meatal stenosis5–16.3% (SR) / 4–40% (individual series)Higher; not well characterisedMost common urethral complication; usually requires meatotomy[13][14]
Misdirected stream9.5–33%33–55%Major surgeon–patient gap[15]
Voiding dysfunction5.6–33%47–66%Hesitancy, weak stream, straining[15]
Urinary incontinence4–19.3%23–33%Stress and/or urge[15]
Urethral stricture10–18%—May present as obstructive voiding[14]
Urethrocutaneous / urethrovaginal fistula0.9–3%—Rare; may require operative repair
Spraying streamWithin "urinary symptoms"CommonMeatal-configuration and periurethral-tissue related
DribblingWithin "urinary symptoms"CommonResidual spongiosum or urethral diverticulum

The Blasdel 2024 "surgical complication blind spots" analysis is the central evidence: surgeon-reported voiding dysfunction ranges 5.6–33% but patient-reported 47–66%; misdirected stream 9.5–33% surgeon vs 33–55% patient. Urinary complications constitute a substantial blind spot in the existing literature; the review recommends adopting the IDEAL framework (Idea / Development / Exploration / Assessment / Long-term study) for future research.[15]

Meatal stenosis — the most common urethral complication​

Rates 4–40% across series.[14]

Pathophysiology — circumferential scarring; inadequate spatulation; suture-line tension; distal-stump ischemia; chronic skin-mucosal-junction inflammation.

Risk factors — inadequate spatulation, excessive tension, wound infection / dehiscence, circumcision status (less periurethral tissue).

Management:[14][16]

  • Office meatotomy — first-line; local anaesthesia.
  • Formal meatoplasty — for recurrent / severe stenosis; scar excision + local tissue flap reconstruction.
  • Serial dilation — temporising only; high recurrence.
  • High-volume centres achieve very low rates — Levy 2019 (n = 240): only 0.4% (1/240) required reoperation for meatal stenosis.[9]

Misdirected urinary stream​

Patient-reported in 33–55%:[15]

  • Meatal position — too anterior (close to clitoris) → anterior-directed stream.
  • Periurethral tissue architecture — labial / clitoral-hood deflection.
  • Residual corpus spongiosum — bulky periurethral spongiosum alters stream dynamics.
  • Meatal shape — circular vs slit-like.
  • Labial fusion / webbing — posterior introital webbing redirects stream.

Management: voiding-position adjustment, tissue manipulation, or surgical revision (meatoplasty with repositioning, periurethral debulking, labial revision). In the NYU vulvar-revision series, urologic complaints were present in 48.6% (17/35) of revision patients.[17]

Voiding dysfunction​

Patient-reported 47–66% vs surgeon-reported 5.6–33%.[15] Includes obstructive (hesitancy, weak stream, straining, incomplete emptying), irritative (frequency, urgency, nocturia), and incontinence. Contributors:[15][18]

  • Shortened urethra reduces functional length and closure pressure.
  • Pelvic-floor dysfunction affects up to 94.1% of transgender individuals after genital surgery — Motiwala 2026 narrative review.[18]
  • Altered pelvic anatomy from canal creation changes urethra–pelvic-floor relationships.
  • Pelvic-floor physical therapy (PFPT) pre- and post-operatively can significantly reduce dysfunction.[18]

Impact of Surgical Technique on Urethral Outcomes — Raigosa Refinement Data​

The Raigosa refinement series provides the strongest direct evidence that periurethral tissue architecture impacts urethral outcomes. Adding labia-minora + clitoral-hood creation to the standard technique:[19]

  • Neomeatal stenosis 15.5% → 1.5% (p = .003)
  • Hemorrhage 31% → 12.5%
  • Aesthetic-revision need 20.3% → 4.6%
  • Wound dehiscence 9.7% → 20.3% (the only outcome that worsened)

Implication: the tissue surrounding the neomeatus — not just urethral shortening and spatulation itself — drives long-term meatal patency and urinary function.

Revision Urethroplasty​

Urethral revision is present in 48.6% (17/35) of patients undergoing vulvar revision at NYU.[17]

Indications — misdirected stream, meatal stenosis, spraying / splashing, periurethral fullness from residual spongiosum, urethral diverticulum.

Techniques:[16][17][20][21]

  • Meatoplasty — stenosis-tissue excision + re-spatulation + reconstruction.
  • Meatal repositioning — to a more anatomically favourable position.
  • Periurethral tissue debulking — excision of excess corpus spongiosum.
  • Dorsal meatotomy — simple widening incision.
  • V-flap meatoplasty — advancement flap to widen and redirect.
  • Buccal mucosal graft meatoplasty — for recurrent / severe stenosis, analogous to cisgender female urethral reconstruction.[21]

Special Considerations​

  • Prior hormone therapy — long-term estradiol may cause urethral-mucosal atrophy and corpus-spongiosum thinning, but Gaither 2018 (n = 330) found years on HRT were not associated with complications.[22]
  • Prior orchiectomy — scrotal-skin contracture may indirectly affect periurethral tissue architecture.
  • Prostate — remains in situ, anterior to the neovaginal canal; examined vaginally.[12] Prostatic urethra unchanged. PSA-screening guidelines apply as for cisgender males but PSA may be lower under estradiol.
  • Continence mechanism — external urethral sphincter preserved across all techniques; despite this, incontinence is reported in 4–33%, implying that altered pelvic-floor anatomy and shortened urethra compromise continence in a subset. PFPT pre- and post-operatively recommended.[15][18]

Urinary Tract Infections​

Shortened urethra → higher UTI rate post-vaginoplasty, analogous to cisgender female anatomy.[12] Neovaginal microbiome differs from cisgender vaginal microbiome and may lack protective Lactobacillus species, potentially contributing to periurethral colonisation with uropathogens. Standard UTI evaluation and treatment apply with site-specific testing based on symptoms and sexual history. Persistent incontinence should prompt urology / surgical-team referral.[12]

Evidence Limitations​

Critical gaps in the urethroplasty-specific evidence base:[15]

  • No dedicated studies focus on the urethroplasty component — urethral outcomes are reported as secondary endpoints within larger vaginoplasty series.
  • Surgeon-reported rates substantially underestimate the true urinary-complication burden; patient-reported rates are 2–3× higher for voiding dysfunction, incontinence, and misdirected stream.[15]
  • No standardised definitions for "meatal stenosis," "voiding dysfunction," or "misdirected stream."
  • No validated PROMs specific to urinary function in transfeminine GAS.[15][18]
  • Long-term outcomes beyond 5 years poorly characterised.
  • No comparative studies evaluate different urethroplasty techniques (spatulation length, meatal position, periurethral-tissue management).
  • Blasdel 2024 explicitly recommends the IDEAL framework for future surgical-innovation research in this field.[15]

References​

1. Saylor L, Bernard S, Vinaja X, Loukas M, Schober J. Anatomy of genital reaffirmation surgery (male-to-female): vaginoplasty using penile skin graft with scrotal flaps. Clin Anat. 2018;31(2):140–144. doi:10.1002/ca.23015

2. Morrison SD, Claes K, Morris MP, et al. Principles and outcomes of gender-affirming vaginoplasty. Nat Rev Urol. 2023;20(5):308–322. doi:10.1038/s41585-022-00705-y

3. Carroll PR, Dixon CM. Surgical anatomy of the male and female urethra. Urol Clin North Am. 1992;19(2):339–346.

4. Grimstad F, McLaren H, Gray M. The gynecologic examination of the transfeminine person after penile inversion vaginoplasty. Am J Obstet Gynecol. 2021;224(3):266–273. doi:10.1016/j.ajog.2020.10.002

5. Shoureshi P, Dugi D. Penile inversion vaginoplasty technique. Urol Clin North Am. 2019;46(4):511–525. doi:10.1016/j.ucl.2019.07.006

6. Amend B, Seibold J, Toomey P, Stenzl A, Sievert KD. Surgical reconstruction for male-to-female sex reassignment. Eur Urol. 2013;64(1):141–149. doi:10.1016/j.eururo.2012.12.030

7. Leclère FM, Casoli V, Baudet J, Weigert R. Description of the Baudet surgical technique and introduction of a systematic method for training surgeons to perform male-to-female sex reassignment surgery. Aesthet Plast Surg. 2015;39(6):927–934. doi:10.1007/s00266-015-0552-2

8. Fascelli M, Peters BR, Dy GW, Dugi DD. Gender-affirming clitoroplasty and construction of the clitoro-urethral complex: an anatomy-guided selection of two techniques. Urology. 2024;183:e320–e322. doi:10.1016/j.urology.2023.10.009

9. Levy JA, Edwards DC, Cutruzzula-Dreher P, et al. Male-to-female gender reassignment surgery: an institutional analysis of outcomes, short-term complications, and risk factors for 240 patients undergoing penile-inversion vaginoplasty. Urology. 2019;131:228–233. doi:10.1016/j.urology.2019.03.043

10. Perovic SV, Stanojevic DS, Djordjevic ML. Vaginoplasty in male transsexuals using penile skin and a urethral flap. BJU Int. 2000;86(7):843–850. doi:10.1046/j.1464-410x.2000.00934.x

11. Raigosa M, Avvedimento S, Yoon TS, et al. Male-to-female genital reassignment surgery: a retrospective review of surgical technique and complications in 60 patients. J Sex Med. 2015;12(8):1837–1845. doi:10.1111/jsm.12936

12. Jackson Q, Yedlinsky NT, Gray M. Lifelong care of patients after gender-affirming surgery. Am Fam Physician. 2024;109(6):560–565.

13. Nassiri N, Maas M, Basin M, Cacciamani GE, Doumanian LR. Urethral complications after gender reassignment surgery: a systematic review. Int J Impot Res. 2020;33(8):793–800. doi:10.1038/s41443-020-0304-y

14. Mann RA, Kasabwala K, Kim N, Pariser JJ. The management of complications of feminizing gender affirming genital surgery. Urology. 2021;152:67–73. doi:10.1016/j.urology.2021.01.031

15. Blasdel G, Dy GW, Nikolavsky D, et al. Urinary reconstruction in genital gender-affirming surgery: checking our surgical complication blind spots. Plast Reconstr Surg. 2024;153(4):792e–803e. doi:10.1097/PRS.0000000000010813

16. Morris MP, Wang CW, Lane M, Morrison SD, Kuzon WM. Common revisions after penile inversion vaginoplasty: techniques and clinical outcomes. Plast Reconstr Surg. 2022;149(6):1198e–1201e. doi:10.1097/PRS.0000000000009159

17. Dy GW, Salibian AA, Blasdel G, Zhao LC, Bluebond-Langner R. External genital revisions after gender-affirming penile inversion vaginoplasty: surgical assessment, techniques, and outcomes. Plast Reconstr Surg. 2022;149(6):1429–1438. doi:10.1097/PRS.0000000000009165

18. Motiwala ZY, Misra S, Desai A, et al. Postoperative urogynecologic complications after gender-affirming surgery: a narrative review. Int Urogynecol J. 2026;37(4):805–822. doi:10.1007/s00192-025-06405-6

19. Raigosa M, Avvedimento S, Descarrega J, et al. Refinement procedures for clitorolabiaplasty in male-to-female gender-affirmation surgery: more than an aesthetic procedure. J Sex Med. 2020;17(12):2508–2517. doi:10.1016/j.jsxm.2020.08.006

20. Dy GW, Kaoutzanis C, Zhao L, Bluebond-Langner R. Technical refinements of vulvar reconstruction in gender-affirming surgery. Plast Reconstr Surg. 2020;145(5):984e–987e. doi:10.1097/PRS.0000000000006796

21. Faiena I, Koprowski C, Tunuguntla H. Female urethral reconstruction. J Urol. 2016;195(3):557–567. doi:10.1016/j.juro.2015.07.124

22. Gaither TW, Awad MA, Osterberg EC, et al. Postoperative complications following primary penile inversion vaginoplasty among 330 male-to-female transgender patients. J Urol. 2018;199(3):760–765. doi:10.1016/j.juro.2017.10.013